Drug delivery technologies form an integral part of the pharmaceutical industry owing to their ability to enhance the availability and efficacy of drugs inside a patient's system and extend patents to support the lifecycle management of leading drugs. Based on the route of drug administration, nine different market segments are covered in this report. These segments include drug delivery technologies for oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal routes of administration.
The oral drug delivery technologies represent the largest share (close to 40%) of the overall market, whereas pulmonary, transdermal, and injectable technologies are the high growth segments with an estimated double-digit CAGR. Increasing patient population for chronic ailments (such as diabetes, asthma and COPD), expanding non-traditional therapeutic applications, technological advancements, and the booming demand for minimally invasive drug delivery methods are the key drivers for these markets. However stringent regulatory processes and the difficulty in striking the right partnership deals remain the key challenges faced by the pharmaceutical and biotechnology companies in this market.
A growing number of companies are investing in technologies including orally disintegrating tablets (ODT), dry powder inhalers (DPIs), pen injectors, auto injectors, buccal films, nasal sprays, intraocular implants, and infusion pumps. The developments in these areas are a result of their proven technology, high dose efficacy, and their ability to offer enhanced patient convenience and compliance.
North America leads the drug delivery technologies market owing to well established healthcare infrastructure and the presence of big pharmaceutical players in this region. However, with increasing disposable income, development of healthcare infrastructure, and rising prevalence of chronic diseases, the pharmaceutical industry in the Asian region, especially in India and China, is booming. Thus, this region represents high revenue potential market for key players.
Some of the drug delivery technologies such as implantable and pulmonary are based on devices. The estimates for such technologies include the market for the device as well as the formulation it delivers. Other technologies such as controlled release and ODT make use of polymeric vehicles and hence, the market for such technologies is estimated based on the market of drugs implementing any such technology.
This report provides insights into different aspects of the market such as competitive landscape, market dynamics, regulatory environment assessment, and market share analysis. It highlights high growth segments that represent enormous opportunities for existing players and new entrants. The report also contains Porter's analysis and value chain analysis, which will help companies take important strategic decisions.
The in-depth analysis provided in the report can help companies:
Take informed decision on entering the high growth segments of the DDT market
Take informed decision about geographic expansion
Derive successful marketing strategies
Planning strategies for efficient supply chain and operations
Find right partner for drug delivery technology
Customer Interested in this report also can view
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Tra